Literature DB >> 19344964

Impact of untreated sleep apnea on prognosis of patients with congestive heart failure.

Qin Luo, Hong-Liang Zhang, Xin-Cao Tao, Zhi-Hui Zhao, Yue-Jin Yang, Zhi-Hong Liu.   

Abstract

128 congestive heart failure (CHF) patients with a median age of 55 years and median left ventricular ejection fraction of 35.4% were followed up for a median period of 35 months. 23 (18%) had no sleep apnea (CHF-N), 55 (43%) had obstructive sleep apnea (CHF-OSA), and 50 (39%) had central sleep apnea (CHF-CSA). At the end of follow-up, mortality was greater in the CHF-CSA group than in the CHF-N group (18.2 vs 6.7/100 person-years, p=0.017). However, after adjusting age and the New York Heart Association functional class central sleep apnea, obstructive sleep apnea, or the severity of sleep apnea are not predictors for survival in CHF. In addition, the percentages of combined events were not significantly different among three groups. Untreated sleep apnea has no independent impact on the prognosis of patients with CHF.
Copyright © 2009 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2009        PMID: 19344964     DOI: 10.1016/j.ijcard.2009.03.050

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  8 in total

Review 1.  Sleep in congestive heart failure.

Authors:  Bhavneesh Sharma; Robert Owens; Atul Malhotra
Journal:  Med Clin North Am       Date:  2010-05       Impact factor: 5.456

Review 2.  Phosphinic peptides as zinc metalloproteinase inhibitors.

Authors:  V Dive; D Georgiadis; M Matziari; A Makaritis; F Beau; P Cuniasse; A Yiotakis
Journal:  Cell Mol Life Sci       Date:  2004-08       Impact factor: 9.261

Review 3.  Epidemiology of Sleep-Disordered Breathing and Heart Failure: What Drives What.

Authors:  Sushma M Dharia; Lee K Brown
Journal:  Curr Heart Fail Rep       Date:  2017-10

4.  Cheyne-stokes respiration during wakefulness in patients with chronic heart failure.

Authors:  Wolfram Grimm; Karl Kesper; Werner Cassel; Nina Timmesfeld; Olaf Hildebrandt; Ulrich Koehler
Journal:  Sleep Breath       Date:  2016-11-28       Impact factor: 2.816

Review 5.  Impact of sleep-disordered breathing and efficacy of positive airway pressure on mortality in patients with chronic heart failure and sleep-disordered breathing: a meta-analysis.

Authors:  Shunichi Nakamura; Kuniya Asai; Yoshiaki Kubota; Koji Murai; Hitoshi Takano; Yayoi Tetsuou Tsukada; Wataru Shimizu
Journal:  Clin Res Cardiol       Date:  2014-10-22       Impact factor: 5.460

6.  Sleep disordered breathing in patients with heart failure: pathophysiology and management.

Authors:  Bhavneesh Sharma; David McSharry; Atul Malhotra
Journal:  Curr Treat Options Cardiovasc Med       Date:  2011-12

Review 7.  [Sleep-related breathing disorders and (resulting) cardiovascular diseases].

Authors:  O Oldenburg; T Bitter; H Fox; D Horstkotte
Journal:  Herz       Date:  2014-02       Impact factor: 1.443

8.  Effects of Sacubitril-Valsartan on Clinical, Echocardiographic, and Polygraphic Parameters in Patients Affected by Heart Failure With Reduced Ejection Fraction and Sleep Apnea.

Authors:  Corrado Pelaia; Giuseppe Armentaro; Mara Volpentesta; Luana Mancuso; Sofia Miceli; Benedetto Caroleo; Maria Perticone; Raffaele Maio; Franco Arturi; Egidio Imbalzano; Francesco Andreozzi; Francesco Perticone; Giorgio Sesti; Angela Sciacqua
Journal:  Front Cardiovasc Med       Date:  2022-04-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.